Recent Advances in Molecular diagnosis curbing the COVID-19

• FDA has approved number of molecular tests for emergency use to address the pandemic confronting the world. • Broad testing will help to identify infected person, enabling proper quarantining, treatment and control. • No comparative analytical information is available about tests approved for emer...

Descripción completa

Detalles Bibliográficos
Autores principales: Aziz, Hafsa, Fatima, Shazia, Iqbal, Huma, Faheem, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831845/
https://www.ncbi.nlm.nih.gov/pubmed/32522596
http://dx.doi.org/10.1016/j.ijid.2020.06.004
_version_ 1783641705849815040
author Aziz, Hafsa
Fatima, Shazia
Iqbal, Huma
Faheem, Mohammad
author_facet Aziz, Hafsa
Fatima, Shazia
Iqbal, Huma
Faheem, Mohammad
author_sort Aziz, Hafsa
collection PubMed
description • FDA has approved number of molecular tests for emergency use to address the pandemic confronting the world. • Broad testing will help to identify infected person, enabling proper quarantining, treatment and control. • No comparative analytical information is available about tests approved for emergency use. • This is a summary of FDA emergency use authorization(EUA) recommended nucleic acid diagnostic modalities.
format Online
Article
Text
id pubmed-7831845
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-78318452021-01-26 Recent Advances in Molecular diagnosis curbing the COVID-19 Aziz, Hafsa Fatima, Shazia Iqbal, Huma Faheem, Mohammad Int J Infect Dis Short Communication • FDA has approved number of molecular tests for emergency use to address the pandemic confronting the world. • Broad testing will help to identify infected person, enabling proper quarantining, treatment and control. • No comparative analytical information is available about tests approved for emergency use. • This is a summary of FDA emergency use authorization(EUA) recommended nucleic acid diagnostic modalities. The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020-08 2020-06-06 /pmc/articles/PMC7831845/ /pubmed/32522596 http://dx.doi.org/10.1016/j.ijid.2020.06.004 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Aziz, Hafsa
Fatima, Shazia
Iqbal, Huma
Faheem, Mohammad
Recent Advances in Molecular diagnosis curbing the COVID-19
title Recent Advances in Molecular diagnosis curbing the COVID-19
title_full Recent Advances in Molecular diagnosis curbing the COVID-19
title_fullStr Recent Advances in Molecular diagnosis curbing the COVID-19
title_full_unstemmed Recent Advances in Molecular diagnosis curbing the COVID-19
title_short Recent Advances in Molecular diagnosis curbing the COVID-19
title_sort recent advances in molecular diagnosis curbing the covid-19
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831845/
https://www.ncbi.nlm.nih.gov/pubmed/32522596
http://dx.doi.org/10.1016/j.ijid.2020.06.004
work_keys_str_mv AT azizhafsa recentadvancesinmoleculardiagnosiscurbingthecovid19
AT fatimashazia recentadvancesinmoleculardiagnosiscurbingthecovid19
AT iqbalhuma recentadvancesinmoleculardiagnosiscurbingthecovid19
AT faheemmohammad recentadvancesinmoleculardiagnosiscurbingthecovid19

Ejemplares similares